Want to see IN:MAXHEALTH full AI Analyst Report?
MAXHEALTH Stock Chart & Stats
₹1202.35
₹4.85(0.40%)
At close: 4:00 PM EST
₹1202.35
₹4.85(0.40%)
Day’s Range― - ―
52-Week Range₹903.50 - ₹1,278.75
Previous CloseN/A
Volume2.66M
Average Volume (3M)80.22K
Market Cap
₹983.01B
Enterprise Value₹968.05K
Total Cash (Recent Filing)₹7.01B
Total Debt (Recent Filing)₹34.78B
Price to Earnings (P/E)68.0
Beta1.13
Next Earnings
Oct 30, 2026EPS Estimate
4.07Next Dividend Ex-DateN/A
Dividend Yield0.2%
Share Statistics
EPS (TTM)14.83
Shares Outstanding973,273,440
10 Day Avg. Volume58,776
30 Day Avg. Volume80,220
Financial Highlights & Ratios
PEG Ratio1.90
Price to Book (P/B)8.67
Price to Sales (P/S)11.13
P/FCF Ratio626.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)19.5
Revenue Forecast (FY)₹119.90B
Bulls Say, Bears Say
Bulls Say
Revenue Scale & Operating ProfitabilitySustained multi-year revenue growth with solid operating margins indicates the core hospital network is scaling effectively. Durable operating profitability supports reinvestment in facilities and talent, underpins margins even with cyclical patient volumes, and enables long-term expansion plans.
Tertiary/quaternary Services MixA concentrated offering of high-complexity specialties (cardiac, oncology, transplants) drives higher average revenue per occupied bed and referral moat. These program-driven services sustain demand, justify premium pricing, and create durable clinical differentiation versus general-care competitors.
Balance Sheet Resilience & Improving ROEA strong equity base and rising ROE from earlier years give the company financial flexibility to fund capex and strategic initiatives. This improving return profile supports long-term capital allocation and helps absorb shocks absent excessive leverage when historically low-debt levels are restored.
Bears Say
Sharp Debt Increase In 2026A recent marked rise in debt elevates refinancing and interest-rate sensitivity relative to prior low-leverage years. Higher leverage can constrain strategic flexibility, increase interest costs, and raise the risk profile if cash generation does not reliably cover servicing and covenant needs over the medium term.
Volatile, Deteriorating Free Cash FlowWeak and volatile FCF, with operating cash covering only ~80% of net income and FCF roughly ~34% of net income in 2025, signals inconsistent cash conversion. This erodes the firm's ability to self-fund capex, reduce debt, or sustain payouts without relying on external financing.
Margin Pressure & Lower Operating Profit In 2026Eroding net margins and a decline in operating profit point to cost or mix pressures that may persist. If structural margin contraction continues, it will reduce reinvestable earnings and weaken returns on invested capital, limiting long-term growth funding and strategic initiatives.
Max Healthcare Institute Ltd News
MAXHEALTH FAQ
What was Max Healthcare Institute Ltd’s price range in the past 12 months?
Max Healthcare Institute Ltd lowest stock price was ₹903.50 and its highest was ₹1278.75 in the past 12 months.
What is Max Healthcare Institute Ltd’s market cap?
Max Healthcare Institute Ltd’s market cap is ₹983.01B.
When is Max Healthcare Institute Ltd’s upcoming earnings report date?
Max Healthcare Institute Ltd’s upcoming earnings report date is Oct 30, 2026 which is in 74 days.
How were Max Healthcare Institute Ltd’s earnings last quarter?
Max Healthcare Institute Ltd released its earnings results on Aug 13, 2026. The company reported ₹3.7 earnings per share for the quarter, missing the consensus estimate of ₹4.073 by -₹0.373.
Is Max Healthcare Institute Ltd overvalued?
According to Wall Street analysts Max Healthcare Institute Ltd’s price is currently Overvalued.
Does Max Healthcare Institute Ltd pay dividends?
Max Healthcare Institute Ltd pays a Annually dividend of ₹2 which represents an annual dividend yield of 0.2%. See more information on Max Healthcare Institute Ltd dividends here
What is Max Healthcare Institute Ltd’s EPS estimate?
Max Healthcare Institute Ltd’s EPS estimate is 4.07.
How many shares outstanding does Max Healthcare Institute Ltd have?
Max Healthcare Institute Ltd has 973,273,440 shares outstanding.
What happened to Max Healthcare Institute Ltd’s price movement after its last earnings report?
Max Healthcare Institute Ltd reported an EPS of ₹3.7 in its last earnings report, missing expectations of ₹4.073. Following the earnings report the stock price went up 0.109%.
Which hedge fund is a major shareholder of Max Healthcare Institute Ltd?
Currently, no hedge funds are holding shares in IN:MAXHEALTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Max Healthcare Institute Ltd
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Aster DM Healthcare Ltd.
―
Fortis Healthcare Ltd.
―
Global Health Limited
―
Narayana Hrudayalaya Ltd.
―